Thomas B. King joins Vivus' Board of Directors

Thomas B. King has been appointed to Vivus' board of directors, a biopharmaceutical company working on therapies for unmet medical needs.

King's nearly 40 years of pharmaceutical experience ranges from large to development-stage pharmaceutical companies.

He has served as an independent biotechnology consultant since August 2016.

Previously, King served as President, Chief Executive Officer and a member of the board of directors of Alexza Pharmaceuticals.

Prior to this, he served as President, Chief Executive Officer and a member of the board of directors of Cognetix.

From January 1994 to February 2001, King held various senior executive positions at Anesta Corporation, including President and Chief Executive Officer. He was a member of the board of directors until it was acquired by Cephalon.

King currently serves on the board of directors of Faraday Pharmaceuticals ans also also serves as a mentor at SPIRE Bioventures, a multi-disciplinary consortium aiding biotechnology entrepreneurs.

Additionally, he serves as an Advisory Board Member of the University of Colorado BioFrontiers Institute. King received a BA in chemistry from McPherson College and an MBA from the University of Kansas Graduate School of Business.

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

NCEs target cancer

As the number of NCE approvals continues to rise, researchers are looking increasingly at anticancer treatments, particularly those involving new tyrosine kinase inhibitors. Dr Sarah Houlton sums up the latest arrivals on the scene
Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Ardena's nanomedicines facility marks expansion with first GMP approval

The EUR €20m expansion to the nanomedicines facility at Pivot Park has achieved operational status by the Dutch Healthcare Authority
Research & Development

Compact process thermostat for efficient temperature control in the laboratory

The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
Manufacturing

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

The award recognises employers that create an outstanding experience for employees
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Subscribe now